Methocarbamol Safety and Driving Impairment

Central Nervous System Effects

• Common side effects of methocarbamol include drowsiness and dizziness, which directly compromise driving safety. 1

• Methocarbamol can cause bradycardia and hypotension, which may lead to sudden impairment while driving. 2

• Cardiovascular effects of methocarbamol pose particular danger for commercial drivers who must maintain alertness and quick reaction times over extended periods. 1

Framework for Evaluating Driving Impairment

• Medications affecting arousal function (drowsiness, somnolence) are considered to have clinically meaningful driving impairment potential. 3, 4

• The standard for assessing driving impairment uses blood alcohol concentration as a benchmark, with increased crash risk at BAC ≥0.05%. 5

Alternative Treatment Approaches

• For truck drivers requiring muscle relaxation, non-pharmacologic interventions should be considered first. 6

• Cyclobenzaprine at low doses (5 mg three times daily) may be an alternative to methocarbamol with more predictable effects, though it also carries driving impairment warnings. 6

Tolerance Development Considerations

• Some antiseizure medications show reduced driving impairment with chronic use. 7, 4

Methocarbamol and Driving Impairment

Introduction to Driving Impairment Risk

• Medications affecting arousal function, such as those causing drowsiness and somnolence, are considered to have clinically meaningful driving impairment potential, according to the American Academy of Sleep Medicine 8, 9

Clinical Considerations for Driving Safety

• Unlike some antiseizure medications, tolerance to methocarbamol's CNS effects does not develop with chronic use, and patients should be advised accordingly, as recommended by the National Highway Traffic Safety Administration 10, 11